# Cost Effectiveness of Glargine Insulin Versus NPH Insulin

> **NCT01832935** · PHASE4 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 200 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** Insulin NPH

## Key facts

- **NCT ID:** NCT01832935
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2013-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832935, "Cost Effectiveness of Glargine Insulin Versus NPH Insulin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01832935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*